Endovascular Function in Atrial Fibrillation (AF) Patients
- Conditions
- PAT Result
- Registration Number
- NCT02062957
- Lead Sponsor
- Beijing Chao Yang Hospital
- Brief Summary
1. recruit 50 patients with atrial fibrillation and 30 controls
2. endovascular function assessment with Peripheral Arterial Tonometry (PAT)
3. follow up the occurence of AF
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
- ≥2 paroxysmal (electrocardiographic documentation of at least 1) AF episodes lasting ≥1 hour in duration: (that terminate spontaneously within 7 days or cardioversion is performed within 48h of AF onset): or
- electrocardiographic documentation of 1 persistent AF episode: (sustained for ≥7 days or cardioversion is performed more than 48h after AF onset): or
- electrocardiographic documentation of 1 longstanding persistent AF episode: (continuous AF of duration >1 year).
Exclusion Criteria
- patients with cerebralvascular disease
- patients with coronary disease
- patients with peripheric artery disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method endovascular function results Up to 24 weeks. The method to assess the endovascular function is PAT. The index is Reactive hyperemia index (RHI). RHI between patients and control will be compared.
- Secondary Outcome Measures
Name Time Method predictive effect of endovascular function on recurrence of AF Up to 1 year We will do the multi-logistic analysis of the recurrence of AF.
Trial Locations
- Locations (1)
Beijing Chaoyang Hospital
🇨🇳Beijing, China